20 May 2014
The packaging of Complamin® Retard 500 mg has been renewed; tablets are now supplied in a container instead of blister strips. Furthermore, the (controlled release) tablets are now film coated instead of dragees (sugar coating).
On 31st December 2013 ACE Pharmaceuticals has received permission from the Dutch Healthcare Inspectorate to supply Complamin Retard 500 mg as non-licensed medicine.
Complamin Retard is used for the treatment of symptoms resulting from poor blood circulation, particularly in the upper body, like Raynaud’s Syndrome (vaso-spastic syndrome). Complamin Retard is also prescribed for hypercholesterolemia.
In the Netherlands, supply of Complamin Retard is subject to the following conditions:
This way, patients who cannot change to a licensed alternative still have access to adequate pharmaceutical care.